Hongene will focus on developing and scaling production of key capping reagents—essential components of mRNA therapeutics—emphasizing accessibility, transparency, and global deployment
Pangea will use its integrated validation platform and regulatory expertise to oversee analytical and clinical validation of Gene Solutions’ multi-omics technologies.
Company to launch product after the expiry of semaglutide patent in India
Lupin’s double ‘A’ rating in Climate and Water exemplifies its steadfast commitment to sustainability
Plant 1 continues to serve as a core manufacturing hub for oral solid dosage forms
The RMAT designation accelerates the development of regenerative medicine therapies for serious or life-threatening diseases
The collaboration will focus on enhancing surgeon capabilities, developing structured training pathways, and promoting the adoption of robotic-assisted surgery in both routine and complex procedures
The collaboration aims to accelerate the delivery of challenging DNA motifs with speed, precision, and reliability
Waskyra is an ex vivo gene therapy that uses patients’ own CD34+ hematopoietic stem and progenitor cells, genetically engineered with a lentiviral vector
Over 8.8?million Indians aged 60 and above currently live with dementia,
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
